Market Closed

TTRX
Turn Therapeutics
$ 9.35
-7.70%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Turn Therapeutics News

Latest Turn Therapeutics Stock News & TTRX Headlines

Turn Therapeutics Provides Corporate Updates and Reports Third Quarter 2026 Financial Results
6 days ago | gurufocus.com
Turn Therapeutics Provides Corporate Updates and Reports Third Quarter 2026 Financial Results
6 days ago | businesswire.com
Turn Therapeutics' GX-03 Earns “Developmental Immunology Solution of the Year” in 2026 BioTech Breakthrough Awards Program
10 days ago | businesswire.com
Turn Therapeutics Appoints Former CDC Director Robert R. Redfield, M.D., as Chief Scientific Officer
2 months ago | gurufocus.com
Turn Therapeutics Announces New Peer-Reviewed Research Showing GX-03 Selectively Reduces Key Drivers of Skin Inflammation and Itch
3 months ago | gurufocus.com
Turn Therapeutics Provides Corporate Updates and Reports Second Quarter 2026 Financial Results
3 months ago | businesswire.com
Turn Therapeutics to Ring the Nasdaq Closing Bell on Monday, August 10, 2026
4 months ago | gurufocus.com
Turn Therapeutics Refines GX-03 Eczema Trial After Interim Data, Eyes 2026 Readout
4 months ago | marketbeat.com
Why Is Turn Therapeutics Stock Trading Higher Today?
4 months ago | benzinga.com
Turn Therapeutics Announces Final Stage 2 Design and Data-Driven Expansion of GX-03 Phase 2 Program in Atopic Dermatitis
4 months ago | businesswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

TTRX
Turn Therapeutics
$ 9.35
-7.70%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago